Walgreens Boots Alliance, Inc. is the largest drugstore chain in the U.S., operating both pharmacy and wellbeing services under the names Walgreens, Duane Reade and Boots Alliance Healthcare.
Some plans on infrastructure spending include fighting the opioid epidemic while improving rural healthcare, home healthcare services and high-speed broadband internet in a rural expansion. A good public-private alliance could be formed with Walgreens, as the company has stores in many rural towns across the country.
Walgreens stock closed Tuesday at $74.95, down 9.4% since the end of 2016 but up 17.4% since setting its 52-week low of $63.82 on Oct. 27. The stock set its 52-week intraday high of $88.00 on Feb. 21, 2017, and is in correction territory since then, down 14.8%.
Walgreens reports earnings before the opening bell on Thursday, Jan. 4, and analysts expect the company to post earnings per share between $1.27 and $1.30. The pharmacy is expected to benefit from new prescription pharmacy partnerships, including those recommended by Medicare and Medicaid. Shares of Walgreens were hurt by the notion that Amazon.com, Inc. would expand into prescription drugs, but that plan seems to be hold. (See also: Walgreens CEO: Amazon Not Yet a Major Rival.)
Walgreens has a market-neutral P/E ratio of 19.21, and the drug store giant has a modest dividend yield of 2.10%. …read more
Read more here: Walgreens to Benefit From Urban Healthcare Reform
Category: WBA, AMZN